awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35012335-0CE3DD6E-5C46-4935-ADCA-10D4B00A18BE
Q35012335-0CE3DD6E-5C46-4935-ADCA-10D4B00A18BE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35012335-0CE3DD6E-5C46-4935-ADCA-10D4B00A18BE
Safety, efficacy, and pharmacokinetics/pharmacodynamics of daclizumab (anti-CD25) in patients with adult T-cell leukemia/lymphoma.
P2860
Q35012335-0CE3DD6E-5C46-4935-ADCA-10D4B00A18BE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35012335-0CE3DD6E-5C46-4935-ADCA-10D4B00A18BE
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a4f1633c38c67f23c48c4e37b9485296a8848ebd
P2860
Daclizumab in active relapsing multiple sclerosis (CHOICE study): a phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon beta.